A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials.
- Citation:
- Cancer vol 109 (4) 787-95
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Comprehensive
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Mashele M Huschka Sumithra J Mandrekar Paul L Schaefer James R Jett Jeff A Sloan
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- NCCTG-N0021, NCCTG-N0022, NCCTG-95-20-53, NCCTG-95-24-51, NCCTG-95-24-52, NCCTG-97-24-51, NCCTG-98-24-52
- Phases:
- 2, 3
- Keywords:
- Activities of Daily Living, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Endpoint Determination, Female, Humans, Lung Neoplasms, Male, Middle Aged, Quality of Life, Radiotherapy, Sickness Impact Profile